Keywords: genzyme, market, argus, tretinoin, lf, pharmaceuticals, tretinoinlf

GENZYME TO MARKET ARGUS' TRETINOIN LF

Article | 20 September 1993

Genzyme will market Argus Pharmaceuticals' TretinoinLF (a lipid-based intravenous form of tretinoin), an anticancer drug in Phase I testing for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing

Related Drugs

Atralin

Tretinoin

Vesanoid

Nystatin

Go to drug listing